Evidence map›Paper›PMID 40201235›Full record

ArticleBioinformatics advances2025

Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma.

Lujun Shen, Tao Zhang, Jian Xu, Yiquan Jiang, Fei Cao, Qifeng Chen, Chen Li, Gulijiayina Nuerhashi, Wang Li, Peihong Wu and 1 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lujun ShenDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Tao ZhangDepartment of Information, Nanfang Hospital, Southern Medical University, Guangzhou 510060, P. R. China.
Jian XuZhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, P. R. China.
Yiquan JiangDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Fei CaoDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Qifeng ChenDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Chen LiDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Gulijiayina NuerhashiDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Wang LiDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Peihong WuDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Weijun FanDepartment of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.ORCID https://orcid.org/0000-0002-8757-647X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Patients with intermediate stage hepatocellular carcinoma (HCC) require repeated disease monitoring, prognosis assessment, and treatment planning. A novel machine learning model called survival path mapping (SP) model was developed, while its performance as compared with conventional machine learning models remains unknown. Between January 2007 and December 2018, the time-series data of 2644 intermediate stage HCC patients from four medical centers in China were reviewed and included. Static machine learning models by Gaussian Naive Bayes (GNB), support vector machine (SVM), and random forest (RF) for the prediction of survivorship were built based on data at initial admission. Longitudinal data divided into different time slices were utilized for the construction of the SP model. The time-dependent Results: The training set, internal testing set, and external testing set consisted of 1560, 670, and 414 HCC patients, respectively. The survival path model had superior or non-inferior performance in prognosis prediction compared to GNB and RF models since the 12th month after initial diagnosis in the training set and the external testing set. The survival path model had higher time-dependent Availability and implementation: The parameters of models are provided in the manuscript.

Identifiers

PMID40201235
PMCPMC11978388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.